Abstract
Background: Triazavirin (2-methylsulfanyl-6-nitro[1,2,4]triazolo[5,1-c][1,2,4] triazin-7(4H)-one, TZV) is an antiviral drug synthesized. TZV is being investigated for potential application against the Coronavirus 2019-nCoV.
Aims and Objectives: In order to find candidate drugs for 2019-nCoV, we have carried out a computational study to screen for effective available drug Triazavirin (C5H4N6O3S) which may work as inhibitor for the Mpro of 2019-nCoV.
Methods: In the present work, first time the molecular structure of title molecule has been investigated using Density Functional Theory (DFT/B3LYP/MidiX) in gas phase.
Results: The molecular HOMO-LUMO, excitation energies and oscillator strengths of investigated compound have also been calculated and presented. The interaction of TZV compound with the Coronavirus was performed by molecular docking studies.
Conclusion: Therefore, TZV can be used for potential application against the Coronavirus 2019-nCoV.
Keywords: Triazavirin, coronavirus, DFT, electronic properties, molecular docking, HOMO-LUMO.
Current Molecular Medicine
Title:Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study
Volume: 21 Issue: 8
Author(s): Siyamak Shahab and Masoome Sheikhi*
Affiliation:
- Independent Researcher, Gonbad-e-Kavoos,Iran
Keywords: Triazavirin, coronavirus, DFT, electronic properties, molecular docking, HOMO-LUMO.
Abstract:
Background: Triazavirin (2-methylsulfanyl-6-nitro[1,2,4]triazolo[5,1-c][1,2,4] triazin-7(4H)-one, TZV) is an antiviral drug synthesized. TZV is being investigated for potential application against the Coronavirus 2019-nCoV.
Aims and Objectives: In order to find candidate drugs for 2019-nCoV, we have carried out a computational study to screen for effective available drug Triazavirin (C5H4N6O3S) which may work as inhibitor for the Mpro of 2019-nCoV.
Methods: In the present work, first time the molecular structure of title molecule has been investigated using Density Functional Theory (DFT/B3LYP/MidiX) in gas phase.
Results: The molecular HOMO-LUMO, excitation energies and oscillator strengths of investigated compound have also been calculated and presented. The interaction of TZV compound with the Coronavirus was performed by molecular docking studies.
Conclusion: Therefore, TZV can be used for potential application against the Coronavirus 2019-nCoV.
Export Options
About this article
Cite this article as:
Shahab Siyamak and Sheikhi Masoome *, Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study, Current Molecular Medicine 2021; 21 (8) . https://dx.doi.org/10.2174/1566524020666200521075848
DOI https://dx.doi.org/10.2174/1566524020666200521075848 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Non-Peptidic GnRH Receptor Antagonists
Current Medicinal Chemistry 1,2,3-Triazine Scaffold as a Potent Biologically Active Moiety: A Mini Review
Mini-Reviews in Medicinal Chemistry Decision Tree Methods in Pharmaceutical Research
Current Topics in Medicinal Chemistry Human Rhinovirus 3C Protease as a Potential Target for the Development of Antiviral Agents
Current Protein & Peptide Science Targeting Infectious Coronavirus Disease 2019 (COVID-19) with Artificial Intelligence (AI) Applications: Evidence Based Opinion
Infectious Disorders - Drug Targets Design of Cathepsin K Inhibitors for Osteoporosis
Current Topics in Medicinal Chemistry Role of Microspheres in Drug Delivery-An Overview
Drug Delivery Letters Short- and Long-Term Survival of Nonsurgical Intensive Care Patients and its Relation to Diagnosis, Severity of Disease, Age and Comorbidities
Current Aging Science Discovery of Anticoagulant Drugs: A Historical Perspective
Current Drug Discovery Technologies Describing Evolution of Hemagglutinins from Influenza A Viruses Using a Differential Equation
Protein & Peptide Letters Chest Radiograph (CXR) Manifestations of the Novel Coronavirus Disease 2019 (COVID-19): A Mini-review
Current Medical Imaging Synthetic Glycosides and Glycoconjugates of Low Molecular Weight Natural Products
Current Pharmaceutical Design Challenges and Perspectives in the Discovery of Dengue Virus Entry Inhibitors
Current Medicinal Chemistry Bioavailability of Endomorphins and the Blood-brain Barrier- A Review
Medicinal Chemistry Veno-Arterial Extracorporeal Membrane Oxygenation in the Adult: A Bridge to the State of the Art
Current Cardiology Reviews Urinary Steroids Measured by Modern Separation Techniques and Applied as Biomarkers in Stress Studies
Current Pharmaceutical Analysis Peptide-based Self-assembly: Design, Bioactive Properties, and Its Applications
Current Pharmaceutical Design Unsafe Abortion: The Silent Endemic; An Avoidable Cause of Maternal Mortality. A Review
Current Women`s Health Reviews Current Treatments and Therapeutic Options for COVID-19 Patients: A Systematic Review
Infectious Disorders - Drug Targets Dystroglycan, A Multifunctional Adaptor Protein for Signal Transduction and A Potential Therapeutic Target
Current Signal Transduction Therapy